<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292158</url>
  </required_header>
  <id_info>
    <org_study_id>2018/184</org_study_id>
    <nct_id>NCT04292158</nct_id>
  </id_info>
  <brief_title>The New Golden Standard: the Early Warning Score Algorithm</brief_title>
  <acronym>EAGLE</acronym>
  <official_title>The New Golden Standard: the Early Warning Score Algorithm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Academisch Ziekenhuis Maastricht</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ziekenhuis Oost-Limburg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Liege</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is this study is the development and implementation of a smart algorithm to
      compute an early warning indicator able to predict early patient deterioration.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data will be collected at the three sites using the SomnoTouchTM and MOXTM devices,
      commercially available and CE approved. Every month, the data will be sent to the KUL and UM
      to develop the algorithm. Study centers will also send some pre-defined patient
      characteristics extracted from the patient's EMR to better contextualize the data.

      The EWS formula has a free interpretation of the vital parameters weighting and the vital
      parameters to be taken into account in the scoring system. Therefore, many variants of the
      EWS arose the past decade (i.e. MEWS, NEWS). The algorithm developed in this study should
      define an objective approach for the EWS formula, diminishing the discordances regarding the
      weight per parameter. Using a patient-personalized approach, the definite algorithm should be
      based on the patient's vital parameter measured during his/her whole hospitalization,
      generating a patient-personalized weight per parameter and an overall reliable EWS scoring
      system.

      The EWS score is often only measured twice per day per patient, creating a large window for
      disease worsening. The algorithm developed in this study could be deployed along the wearable
      device developed in the WearIT4Health project. The device would continuously feed the
      algorithm with data acquired from its sensors. Thus, the EWS would be computed every 10
      seconds.

      The EWS scoring system has already been proven to be an effective approach in reducing
      clinical deterioration, reducing the admission to intensive care units and thus overall
      reducing mortality. However, as mentioned above the EWS is measured in a rather low
      frequency. Therefore, estimation of the EWS score via continuous monitored parameters should
      further increase patient survival.

      The primary objective of the EAGLE study is to collect continuously monitored vital and
      activity parameter data and use it to develop an algorithm that can early identify clinical
      deterioration to optimize the application of the EWS system.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">April 30, 2020</completion_date>
  <primary_completion_date type="Actual">November 4, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Precision of predictive early warning score algorithm</measure>
    <time_frame>Up to 1 week</time_frame>
    <description>Precision defined of truepositives divided by the sum of truepositives and truenegatives. This measure indicates how often the predictive EWS was right in identifying adverse events.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Early Warning Score</condition>
  <arm_group>
    <arm_group_label>Main Group</arm_group_label>
    <description>Hospitalized for at least 1 day clinic stay at the participating hospitals</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SomnoTouch</intervention_name>
    <description>The patient will be equipped with the SomnoTouch device. This device is able to record and estimate the following data:
ECG data PPG data Heart rate Respiration rate Blood pressure (mmHg) Oxygen saturation (%).
All patient will be stored for further analysis.</description>
    <arm_group_label>Main Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MOX</intervention_name>
    <description>The patient will be equipped with the MOX device. This device is able to record and estimate the following data:
Accelerometers data Activity Body posture
All patient will be stored for further analysis.</description>
    <arm_group_label>Main Group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospitalized for at least 1 day at the participating hospitals excluding patients admitted
        at high intensity units: Intensive care units, Coronary care units, Emergency room.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Exclusion Criteria:

          -  Suffering from infectious disease

          -  Participating to another study that could intervene with the study results (e.g.
             experimental medication that could affect the heart rate).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrizio Lancellotti</last_name>
    <role>Principal Investigator</role>
    <affiliation>Liège University Hospital - CHU de Liège</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pierre Delanaye</last_name>
    <role>Study Director</role>
    <affiliation>Liège University Hospital - CHU de Liège</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arnaud Ancion</last_name>
    <role>Study Director</role>
    <affiliation>Liège University Hospital - CHU de Liège</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Pieter Vandervoort</last_name>
    <role>Study Director</role>
    <affiliation>Department of Cardiology and Department Future Health, Ziekenhuis Oost-Limburg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dianne de Korte-de Boer</last_name>
    <role>Study Chair</role>
    <affiliation>Maastricht University Medical Centre, department of Anesthesiology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ziekenhuis Oost-Limburg</name>
      <address>
        <city>Genk</city>
        <state>Limbourg</state>
        <zip>3600</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center+</name>
      <address>
        <city>Maastricht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Netherlands</country>
  </location_countries>
  <reference>
    <citation>Gerry S, Birks J, Bonnici T, Watkinson PJ, Kirtley S, Collins GS. Early warning scores for detecting deterioration in adult hospital patients: a systematic review protocol. BMJ Open. 2017 Dec 3;7(12):e019268. doi: 10.1136/bmjopen-2017-019268.</citation>
    <PMID>29203508</PMID>
  </reference>
  <reference>
    <citation>Jarvis S, Kovacs C, Briggs J, Meredith P, Schmidt PE, Featherstone PI, Prytherch DR, Smith GB. Aggregate National Early Warning Score (NEWS) values are more important than high scores for a single vital signs parameter for discriminating the risk of adverse outcomes. Resuscitation. 2015 Feb;87:75-80. doi: 10.1016/j.resuscitation.2014.11.014. Epub 2014 Nov 26.</citation>
    <PMID>25433295</PMID>
  </reference>
  <reference>
    <citation>Moon A, Cosgrove JF, Lea D, Fairs A, Cressey DM. An eight year audit before and after the introduction of modified early warning score (MEWS) charts, of patients admitted to a tertiary referral intensive care unit after CPR. Resuscitation. 2011 Feb;82(2):150-4. doi: 10.1016/j.resuscitation.2010.09.480. Epub 2010 Nov 5.</citation>
    <PMID>21056524</PMID>
  </reference>
  <reference>
    <citation>Ajami S, Teimouri F. Features and application of wearable biosensors in medical care. J Res Med Sci. 2015 Dec;20(12):1208-15. doi: 10.4103/1735-1995.172991. Review.</citation>
    <PMID>26958058</PMID>
  </reference>
  <reference>
    <citation>Smith MEB, Chiovaro JC, O'Neil M, Kansagara D, Quinones A, Freeman M, Motu'apuaka M, Slatore CG. Early Warning System Scores: A Systematic Review [Internet]. Washington (DC): Department of Veterans Affairs; 2014 Jan. Available from http://www.ncbi.nlm.nih.gov/books/NBK259026/</citation>
    <PMID>25506953</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>October 1, 2019</study_first_submitted>
  <study_first_submitted_qc>February 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Liege</investigator_affiliation>
    <investigator_full_name>Patrizio Lancellotti</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Early warning score</keyword>
  <keyword>Vital parameters</keyword>
  <keyword>Predictive algorithm</keyword>
  <keyword>Medical Devices</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

